These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 20102385

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of raloxifene therapy on plasma renin and aldosterone levels and blood pressure in postmenopausal women.
    Morgante G, Delia A, Musacchio MC, Severi FM, Petraglia F, De Leo V.
    Gynecol Endocrinol; 2006 Jul; 22(7):376-80. PubMed ID: 16864147
    [Abstract] [Full Text] [Related]

  • 3. Effects of long-term transdermal hormone replacement therapy on the renin-angiotensin- aldosterone system, plasma bradykinin levels and blood pressure in normotensive postmenopausal women.
    Ichikawa A, Sumino H, Ogawa T, Ichikawa S, Nitta K.
    Geriatr Gerontol Int; 2008 Dec; 8(4):259-64. PubMed ID: 19149837
    [Abstract] [Full Text] [Related]

  • 4. Different effects of transdermal and oral hormone replacement therapy on the renin-angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women.
    Ichikawa J, Sumino H, Ichikawa S, Ozaki M.
    Am J Hypertens; 2006 Jul; 19(7):744-9. PubMed ID: 16814131
    [Abstract] [Full Text] [Related]

  • 5. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J, Henik RA, Brownfield M, Armstrong J.
    Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
    [Abstract] [Full Text] [Related]

  • 6. Renin inhibitors, angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists: relationships between blood pressure responses and effects on the renin-angiotensin system.
    Schalekamp MA, Derkx FH, van den Meiracker AH.
    J Hypertens Suppl; 1992 Dec; 10(7):S157-64. PubMed ID: 1291650
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of angiotensin-converting enzyme inhibition on plasma aldosterone concentration, plasma renin activity, and blood pressure in spontaneously hypertensive cats with chronic renal disease.
    Steele JL, Henik RA, Stepien RL.
    Vet Ther; 2002 Dec; 3(2):157-66. PubMed ID: 19750747
    [Abstract] [Full Text] [Related]

  • 9. Effects of hormone replacement therapy or raloxifene on ambulatory blood pressure and arterial stiffness in treated hypertensive postmenopausal women.
    da Costa LS, de Oliveira MA, Rubim VS, Wajngarten M, Aldrighi JM, Rosano GM, Neto CD, Gebara OC.
    Am J Cardiol; 2004 Dec 01; 94(11):1453-6. PubMed ID: 15566926
    [Abstract] [Full Text] [Related]

  • 10. Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects.
    Blumenfeld JD, Sealey JE, Mann SJ, Bragat A, Marion R, Pecker MS, Sotelo J, August P, Pickering TG, Laragh JH.
    Am J Hypertens; 1999 May 01; 12(5):451-9. PubMed ID: 10342782
    [Abstract] [Full Text] [Related]

  • 11. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
    Cerasola G, Cottone S, D'Ignoto G, Grasso L, Carone MB, Carapelle E, Contorno A.
    Clin Ther; 1987 May 01; 9(4):390-9. PubMed ID: 3038326
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep 01; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 14. Association of bone metabolism related genes polymorphisms with the effect of raloxifene hydrochloride on bone mineral density and bone turnover markers in postmenopausal women with osteoporosis.
    Zhang ZL, He JW, Qin YJ, Huang QR, Liu YJ, Hu YQ, Li M.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Apr 01; 23(2):129-33. PubMed ID: 16604479
    [Abstract] [Full Text] [Related]

  • 15. The effect of raloxifene on cardiac autonomic regulation in osteoporotic women.
    Gol M, Baris N, Guneri S, Posaci C.
    Am J Obstet Gynecol; 2006 May 01; 194(5):1249-54. PubMed ID: 16647907
    [Abstract] [Full Text] [Related]

  • 16. Effects of hormone therapy on blood pressure and the renin-angiotensin system in postmenopausal women.
    Prime DD, Brosnihan KB, Herrington DM.
    Minerva Cardioangiol; 2007 Aug 01; 55(4):477-85. PubMed ID: 17653023
    [Abstract] [Full Text] [Related]

  • 17. Effects of drospirenone/17-beta estradiol on blood pressure and potassium balance in hypertensive postmenopausal women.
    Preston RA, White WB, Pitt B, Bakris G, Norris PM, Hanes V.
    Am J Hypertens; 2005 Jun 01; 18(6):797-804. PubMed ID: 15925739
    [Abstract] [Full Text] [Related]

  • 18. Raloxifene therapy interacts with serum osteoprotegerin in postmenopausal women.
    Messalli EM, Mainini G, Scaffa C, Cafiero A, Salzillo PL, Ragucci A, Cobellis L.
    Maturitas; 2007 Jan 20; 56(1):38-44. PubMed ID: 16787719
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of enalapril on blood pressure, renal function, and the renin-angiotensin-aldosterone system in cats with autosomal dominant polycystic kidney disease.
    Miller RH, Lehmkuhl LB, Smeak DD, DiBartola SP, Radin J.
    Am J Vet Res; 1999 Dec 20; 60(12):1516-25. PubMed ID: 10622161
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.